HIV drug resistance - A chink in the armor

New England Journal of Medicine

Volumn 347, Issue 6, 2002, Pages 438-439

  Hirsch, Martin S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

DISEASE TRANSMISSION; DRUG SENSITIVITY; EDITORIAL; EDUCATION PROGRAM; FEMALE; FOLLOW UP; GENOTYPE; HEALTH CARE ACCESS; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS DETECTION; WORLD HEALTH ORGANIZATION;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; HIV; HIV INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0037043673     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe020072     Document Type: Editorial

References (12)

1. Antiretroviral drug resistance among subjects recently infected with HIV
2. Acute HIV infection: Impact on the spread of HIV and transmission of drug resistance
3. Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study
4. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire
5. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
6. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
7. Clinical utility of HIV-1 genotyping and expert advice: The Havana trial
8. A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy
9. Use of genotypic resistance to guide HIV therapy: Clinical impact and cost-effectiveness
10. Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavir
11. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
12. Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: Recommendations for the European setting